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Abstract: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease that may result in
arrhythmia, heart failure and sudden death. The hallmark pathological findings are progressive myocyte loss and fibro fatty
replacement, with a predilection for the right ventricle. This study focuses on the adipose tissue formation in cardiomyocyte by
considering the signal transduction pathways including Wnt/ β-catenin and Wnt/Ca2+ regulation system. These pathways are
modelled and analysed using stochastic petri nets (SPN) in order to increase our comprehension of ARVC and in turn its
treatment regimen. The Wnt/ β-catenin model predicts that the dysregulation or absence of Wnt signalling, inhibition of
dishevelled and elevation of glycogen synthase kinase 3 along with casein kinase I are key cytotoxic events resulting in
apoptosis. Moreover, the Wnt/Ca2+ SPN model demonstrates that the Bcl2 gene inhibited by c-Jun N-terminal kinase protein in
the event of endoplasmic reticulum stress due to action potential and increased amount of intracellular Ca2+ which recovers the
Ca2+ homeostasis by phospholipase C, this event positively regulates the Bcl2 to suppress the mitochondrial apoptosis which
causes ARVC.

1 Introduction
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a
heart muscle disease clinically characterised as life-threatening
ventricular arrhythmias. Its prevalence has been estimated to vary
from 1/2500 to 1/5000. ARVC is a major cause of sudden deaths in
young people and specifically in athletes [1]. This disease is
generally characterised by right ventricular (fibro)-fatty
replacement of myocardial tissue with the clinical phenotype
depicting cardiac arrhythmias, sudden cardiac death and heart
failure [2].
Although being investigated from the past two decades, the
molecular mechanisms of ARVC are sparsely spread across
multiple research studies [3–6]. Despite there are several known
disease-causing genes for ARVC, the molecular links among them
have not been delineated. Lack of effective therapies in targeting
the pathophysiology of ARVC further underpins the critical need to
decipher its mechanistic basis [7]. Thus, there is a compelling need
to develop refined disease models which could increase our
understanding of the molecular mechanisms of pathogenesis of
ARVC and allow prediction of experimental designs for testable
hypotheses. Therefore, in this study, we aimed to develop and
present the petri net-based models of two key signalling pathways
(Wnt/ β-catenin and Wnt/Ca2+) which have been demonstrated to
play a role in ARVC [3, 7, 8]. These models are based on our
extensive literature survey effort conducted to first gather all
molecular links in these signalling pathways which was then used
to create biological regulatory networks (BRNs). The BRNs which
encompass the regulatory feedback loops among key molecular
entities in these signalling pathways were then transformed into
respective petri net models (the employed methodologies have
been comprehensively described in our previous work [9–12] and
Section 2 below). These models were then used to simulate and
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predict the dynamical behaviour of the associated BRNs during
homeostasis and pathological conditions that may underpin ARVC.
The predicted results of these models are inline with the previous
experimental observations and thus may have potential therapeutic
implications for treatment of ARVC. To the best of our knowledge,
this is a very first attempt to present an ARVC-based molecular
disease model based on petri net approach which will open avenues
for further experimental research in target identification and may
aid in therapeutic interventions.
The molecular pathogenesis of ARVC has at least two
components including fibroadiposis and cardiac dysfunction. Two
different arms of intracellular signalling of the Wnt pathway are (i)
the Wnt/ β-catenin pathway and (ii) the Wnt/Ca2+ pathway [13],
both have been demonstrated to be deregulated in ARVC and
described comprehensively below.
1.1 Signalling pathways
The gating mechanisms of mechanosensitive cardiomyocytes are
used to modulate the cardiomyocyte responses to genetic
abnormalities and stress of the system. The basis for the mechanotransduction system is formed by the network of complex proteins
through which extracellular matrix (ECM) and sarcomere are
connected with each other. For example, the intracellular signalling
and sarcomere connection with ECM by integrins are performed
via components of complex costamere, which alter the regulation
of transcription in response to distortion of membrane and
properties of contraction. In response to systemic stress, the signal
is initiated which is implemented by mechanosensitive channels of
ions. The signalling pathways are induced by changes in stress of
cardiomyocyte which is connected with progression of cardiac
pathology [14].
350

Fig. 1 Physiological and pathophysiological signaling of Wnt- β-catenin pathway
(a) In the absence of Wnt ligand β-catenin is degraded which gives rise to pathophysiological phenotypes, (b) When Wnt ligand is present then β-catenin will translocate to nucleus
and activates Wnt responsive genes and maintain homeostasis

The important mechanisms of cardiomyocytes such as cell
generation, polarity of the cell, homeostasis of tissues and fate of
cell during the development of embryo are initiated by the Wnt
ligand (secreted glycolipoproteins) [13]. The absence of Wnt
disturbs the Wnt pathway which can cause defects in human birth,
cancer etc. In heart tissue, homeostasis of Wnt/ β-catenin pathway
plays an important role in adults. Dysregulation of this signalling
pathway causes many cardiac pathological conditions such as
hypertrophic cardiomyopathy, myocardial infarction, ARVC.Wnt/
β-catenin is the molecular disease of ARVC in which substitution
of the adipose tissue occurs in the myocardium [15].
The schematic diagram of Wnt/ β-catenin signalling is illustrated
in (Fig. 1). The β-catenin in the cytoplasm is degraded
continuously by Axin complex in the absence of Wnt ligand. The
Axin complex is composed of Axin protein, adenomatous polyposis
coli (APC), glycogen synthase kinase 3 (GSK3) and casein kinase I
(CKI). β-transducin repeats-containing proteins ( β-TrCP) identifies
and degrades β-catenin after the sequential phosphorylation of βcatenin by CK1 and GSK3. This will prevent β-catenin
translocation to the nucleus which will eventually represses the
activation of Wnt target genes by Factor/T-cell-specific
transcription factor (Tcf/Lef) (Fig. 1a). On the other hand in the
presence of Wnt, the β-catenin pathway is initiated (Fig. 1b). Here,
Wnt binds with Frizzled and its co-receptor Factor/T-cell-specific
transcription factor (LRP5/6). The former is a seven-pass
transmembrane protein receptor while its co-receptor is lowdensity lipoprotein. The complex of Wnt-Frizzled (Wnt/Frizz)
activates dishevelled (Dvl) and Axin leading to inhibition of βcatenin phosphorylation. It prevents β-catenin degradation which
then translocates to the nucleus and makes a complex with Tcf/lef
activating downstream Wnt responsive genes (Fig. 1b) [16].
The Wnt ligand binds to FRIZZLED (Frizz) receptor which
further activates many intracellular molecules and signalling
pathways, i.e. diglyceride (DAG), Inositol 1,4,5-trisphosphate (IP3)
and Ca2+ (Fig. 2). The increase of these messengers affects the
functions of the cell. The phospholipase C (PLC) activates the IP3
and DAG are derived from membrane-bound phospholipid
phosphatidyl inositol 4, 5-bisphosphate. The Wnt and Frizz
interaction activates the PLC. The IP3 moves into the cytosol and
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releases extra Ca2+ ions stored and present in the endoplasmic
reticulum (ER) membrane [17].
Ca2+ is a second messenger in the cell which is involved in
different processes of signalling such as cardiac contraction,
hormones secretion, neurotransmission and growth factor etc. Ca2+
influx and efflux into the cell are carried out by voltage-gated
channels (VGCs), energy-dependent apparatuses as well as by
receptor-based signalling. Together they maintain homeostasis in
the cell but cellular perturbations such as stress response in ER in
the initial and late stage of apoptosis disrupt homeostasis and
signalling of Ca2+. Ca2+ plays a major role in cell death and its
overload induce apoptosis [18]. Ca2+ influx into the plasma
membrane activates many basic functions of the cell and the
reloading of Ca2+ in ER after depletion of Ca2+ from the ER store.
The ER Ca2+ ions release and activate the Ca2+ influx to the ER
store [19].
When unfolded proteins aggregate in ER, Bindingimmunoglobulin protein separates from the complex of inositolrequiring protein-1 (IRE1), Protein kinase RNA-like ER kinase
(PERK) and Activating Transcription Factor-6 (ATF6) in turn
activating them. IRE1 then recruits tumour necrosis factor
receptor-associated Factor-2 (TRAF2) and apoptosis-signallingkinase 1, which then results in downstream activation of c-Jun Nterminal protein kinase (JNK) and p38 mitogen-activation protein
kinase (MAPK). The CCAAT enhancer-binding protein
homologous protein (CHOP) is activated by p38 MAPK
phosphorylation while, JNK translocates to the mitochondrial
membrane, where it inhibits Bcl2. The Bcl2-associated X (Bax)
protein and Bcl2 homologous antagonist killer (Bak) protein are
activated by IRE1 which induce inositol 1, 4, 5-triphosphate
receptors (IP3Rs) and causes Ca2+ release from the ER [18].
The influx of extracellular Ca2+ ions into the cell occurs
through Ca2+ VGCs and many ligand-gated channels (LGCs) due
to action potential. Translocation of Ca2+ ions from ER into
cytoplasm occurs through Ryanodine Receptors (RyRs) or IP3Rs.
Increase in the level of intracellular Ca2+ ions due to ER stress
response causes depolarisation of the memebrane. The activation of
Bak and Bax in the membrane of ER allows the Ca2+ release into
the cytosol where it activates the m-Calpain and finally activates
351

Fig. 2 Physiological role of Ca2 + channel during the initiation of action potential. The imbalance of Ca2 + homeostasis causes apoptosis which results in
ARVC

the procaspase-12 which lead to the activation of the caspase
cascade. Ca2+ also move to mitochondria, which lead to the
membrane depolarisation and releases cytochrome c and apoptotic
protease activating factor 1/procaspase-9-regulated is activated to
cause apoptosis. The PERK and ATF6 trigger CHOP that is proapoptotic at downstream. The IRE1 is also activated by ER stress
which further leads to activation of ASK, TRAF, JNK and
procaspase-12 which finally trigger caspase cascade [18].
The regulation of cytoplasmic Ca2+ is carried out at low level
as compared to extracellular Ca2+ through homeostatic mechanism
created by voltage and receptor-operated channels. These
mechanisms are used to maintain equilibrium between Ca2+ inside
the cell and Ca2+ to extracellular space [20]. The Ca2+ efflux is
carried out by plasma membrane calcium ATPase (PMCA) channel
and sodium–calcium exchanger (NCX) which are ATP dependent
membrane pumps. Many physiological processes use proteins
activated by high Ca2+ inclusion in the cell. One of the influx
channels is the N-methyl-D-aspartate receptor, which maintains
Ca2+ influx when it binds to ligand (glu) to get switched ON.
Another type of Ca2+ influx gateway is the voltage-gated Ca2+
channel (VGCC). The VGCC gets switched ON to depolarise the
plasma membrane because of Ca2 + /Na+ ions exchange [21, 22].
The store-operated channels increase Ca2+ ions influx into ER
Ca2+ from the cytoplasm. The Ryanodine (RyRs) and IP3 sensitive
pathways are responsible for the calcium exchange in ER. The Gprotein coupled receptor (GPCR) activates PLC which release
Ca2+ by IP3. The extracellular Ca2+ concentration is managed by
NCX and PMCA channels [20].
1.2 Contribution
The study was conducted to provide a clear understanding of the
role of Wnt/ β-catenin and Wnt/Ca2+ in the progression of ARVC
by investigating the underlying dynamics of associated molecular
entities. The main contribution of this study is the construction of
stochastic petri net (SPN) models of Wnt/ β-catenin and Wnt/Ca2 +
pathways which provide comprehensive insights into the possible
signalling dynamics of associated BRNs during homeostasis and
pathophysiological
conditions.
The
dynamics
of
pathophysiological behaviours of cardiomyocyte analysed through
these models could predict dynamics under different scenarios e.g.
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How the absence of Wnt ligand disrupt the Wnt signalling pathway
to cause apoptosis? How the activators (PP1 and PP2A etc.) and
inhibitors (GSK, Axin, BCl2 etc) regulate the Wnt signalling and
calcium pathways through positive and negative regulatory
feedback loops. The model demonstrates molecular dynamics in
the absence of Wnt signalling where inactivation of Dvl causes the
GSK3 to inhibit the translocation of β-catenin to the nucleus and in
turn leading the cellular apoptosis. Overall, the results demonstrate
an intertwined dysregulation of molecular entities in Wnt
signalling, β-catenin degradation and imbalance of calcium
signalling homeostasis which upon further investigation warrants
the therapeutic implications. Moreover, the predicted results are in
agreement with those observed in previous experiments (see
Section 3).

2 Methodology
The methodological steps followed in this study to model the
biological signalling pathways Wnt/ β-catenin and Wnt/Ca2 + of
ARVC is graphically illustrated in Fig. 3 and explained in-depth in
the following sections.
2.1 Petri net modelling
Petri net is a very dynamic mathematical formalism for modelling
of real systems initially utilised for the biochemical systems in
1939 [21]. After that many biological systems have been modelled
using petri net approach on the basis of its simplicity and flexibility
(some recent examples are [10, 12, 23–25]). These models
facilitate us to present the dynamic behaviour of time-dependent
systems. A mathematical platform as provided by petri nets to
analyse and test the hypothesis of biologists for experiments is now
well established [26–28].
A petri net is a bipartite graph comprising of two types of
nodes, i.e. places (represented by circles) and transitions
(represented by square/rectangle) [29]. The biological entities, e.g.
gene, protein, mRNA, ions and other cellular components are
represented by places (◯) while the biochemical reactions, e.g.
activation, inhibition, dephosphorylating, phosphorylation and
translocation are represented by transitions ◻ [20]. A directed arc
connects a place with a transition. Real numbers or discrete
integers (also called tokens) in the places models the quantities of
the molecular entities they are representing. The flow of these
IET Syst. Biol., 2020, Vol. 14 Iss. 6, pp. 350-367
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Fig. 3 Modelling and analysis workflow. The steps followed in methodology are illustrated

Fig. 4 Unmarked petri net model of Wnt signalling pathway
(a) Wnt/Frizz complex is formed by binding transition. The place β-catenin is dephosphorylated by De-pptransition which regulates Wnt ligand in a positive feed back loop by βcatenin at regulation transition, (b) Marked petri net model has tokens which represent initial marking of the Wnt signalling model

ρ consists of a finite set of places, i.e. ρ = ρ1, ρ2, ρ3, . . . , ρn .
τ consists of a finite set of transitions, i.e. τ = τ1, τ2, τ3, . . . , τn .
ρ ∩ τ = ϕ, both ρ and τ cannot be empty sets.
ε ⊆ ρ × τ ∪ τ × ρ consists of transitions’ edges (input and
output).
• Pre: ρ × τ → N, non-negative values assigned by a weight
function to an input edge.
• Post: τ × ρ → N, non-negative values assigned by a weight
function to an output edge.

quantities between places (pre and post) takes place through a
process called the firing of transitions. An enabled transition
(having sufficient tokens equivalent to or greater than a multiplicity
of the arc weights) may fire modelling the flow of quantities from
pre-places to post-places. At a time instant t, the markings of all
places of a petri net specify its state. Formal semantics of petri nets
given below have been adopted from Ashraf et al. [20]. However,
readers are directed to several recent studies for more insights into
the application and usage of petri nets in modelling biological
systems [29–31].

•
•
•
•

Definition 1: (Unmarked petri net). There are five components
in unmarked petri net P = < ρ, τ and ε, pre, post>. Where

An unmarked petri net is shown in Fig. 4a, for modelling of
Wnt signalling pathway. The places Frizz_R and Wnt ligand form a
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Fig. 5 Wnt signalling pathway using TPN model
(a) The Wnt and Frizz components bind to make a complex Wnt/Frizz. The transitions binding, De-pp and regulation are associated with time delay d1, d2 and d3, respectively. The
transitions are fired when the associated time delay (d1, d2 and d3) is elapsed, (b), (c) Shows specified and usual SPNs. The TPN can be converted into SPN when the deterministic
firing function d changes into a random variable

complex Wnt/Frizz which further activates the Wnt signalling
pathway.
Definition 2: (Marked petri net). The marked petri net (MPN)
⌣
consist of MP = < P, m 0 > where
• P =< ρ, τ, ϵ, pre, post> is an unmarked petri net and
⌣
• m 0 : ρ → Z ≥ 0 is the petri net initial marking.
Definition 3: [Timed petri net (TPN)]. The TPN have TP = <
⌣
MP, f n > where
⌣

• MP =< P, m >> is an MPN.
⌣
• f n: τ → R+ is a function that assigns a positive real number, i.e.
each transition's a time delay.
A TPN has di time delay associated with transition τi. When the
Pre place has sufficient tokens then transition gets enabled and
fired its specific time delay elapsed as shown in Fig. 5a. When the
variables of time delays are random then SPN is used. SPN is
derived from TPN presented in Fig. c [10].
Definition 4: (SPN). An SPN is a marked petri net which is pair
⌣
of MP, Rate where MP = (P, m0) is a MPN (marked petri net) and
+
Rate: τ → R , which is a function from the transition set τ to the
positive finite real numbers set. Rate (τi) = μi, is the transition
firing rate of transitions τi. In equation 1 di have been assigned
random variables of negative exponential for probability
⌣
distribution function f n(t),
⌣

f n(t) = Pr[di ≤ t] = 1 − e− μit

(1)

where, Pr[di ≤ t + dt di > t] = μi ⋅ dt
The firing frequency of transitions and their time-dependent
flow of tokens are simulated over multiple runs to get an average in
SPNs [28]. In order to reproduce the time-dependent dynamic
behaviour of the biological system under study, the firing rates can
be determined either experimentally or inferred by trial and error
[28]. SPN has its underlying semantics of discrete-time Markov
chain and mainly all algorithms for stochastic modelling of
biochemical processes are based on the Gillespie's algorithm
described in [32]. Moreover, the snoopy tool also uses Gillespie's
algorithm for stochastic modelling of petri nets [33–35]. An SPN is
especially suitable for modelling of bio-molecular networks [29].
Several studies have comprehensively described in sufficient
details the inherent stochasticity of different bio-molecular systems
including gene regulation, signalling pathways and other
354

biochemical reactions and we refer our readers to them for more
insights [23, 36].
The SNOOPY tool [37] has been used to design, stimulate and
animate the biological network of signalling pathways previously
and in this study as well [22]. The discrete steps involved in petri
net modelling in this study includes the abstraction of extracted
pathway iteratively; find out the pathway positive and negative
feedback loops to regulate the signalling pathway against ARVC;
petri net model construction, analysis and model verification
through simulation Fig. 3.

3

Results

In this study, the biological signalling networks of Wnt/ β-catenin
and Wnt/Ca2 + pathways for ARVC disease are constructed as
shown in Fig. 6 and 7, respectively. Three SPNs were then
constructed which are presented in Figs. 8–10, respectively.
3.1 Construction of the Wnt/ β-catenin and Wnt/Ca2 + ARVC
pathway
The biological pathways for Wnt/ β-catenin and Wnt/Ca2 +
signalling networks are constructed from a detailed study of
literature review and are presented in Figs. 6 and 7, respectively.
The deregulation in Wnt signal and Ca2 + concentration level cause
the phenotype of ARVC. Fig. 6 shows the absence of Wnt signal
causes the high level of GSK3 and Ck1 which negatively regulates
the pathways and degrades the β-catenin and hence results in
adipose tissues formation and heart failure. There are several
positive and negative feedback loops present in the pathway which
regulates it. Fig. 7 depicts that the action potential increases
cytosolic Ca2+ levels. This in turn creates the ER stress triggering
apoptotic pathways via mcalpin in the cytoplasm. On the other
hand, Ca2+ overload in mitochondria raptures the membrane of
mitochondria and release the cytochrome C in the cytoplasm to
activate the caspase cascades which also stimulate apoptosis. The
ER and Ca2+ in cytoplasm activate the IRE1 which proceed to
activate the pro-apoptoic component JNK, which inhibit the antiapoptotic gene Bcl2. The Bak and Bax are pro-apoptotic
components which can be inhibited by Bcl2. The ER stress
activates CHOP which inhibits Bcl2.
3.2 Modelling approach for ARVC pathway
Based on the BRNs shown in Figs. 6 and 7, three SPNs were
constructed which are presented in Figs. 8–10, respectively. Single
SPN was constructed to model both cases of homeostasis and
pathogenesis for Wnt/ β-catenin signalling pathway (Fig. 8).
Whereas two different SPNs were constructed to model
IET Syst. Biol., 2020, Vol. 14 Iss. 6, pp. 350-367
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Fig. 6 Wnt/ β-catenin signalling pathway shows positive regulation through a positive feedback loop among Wnt, Dvl, β-catenin, Tcf/lef and Bcl2. While
GSK3 and Ck1 negatively regulates β-catenin in the pathway

homeostasis and pathogenesis scenarios for Wnt/Ca2 + signalling
pathway(Figs. 9 and 10, respectively). Usually, different sets of
parameters are sufficient to model different scenarios when
modelling a petri net because of the same underlying molecular
interactions with different rates which was the case for Wnt/ βcatenin pathway. However, we had to construct two SPNs for Wnt/
Ca2 + signalling pathway in order to model and display the
additional molecular events initiated in case of its deregulation.
Software tool SNOOPY (version 2.0.33 for windows) was used to
generate and simulate the model. Every simulation was performed
1000 times. The parameters were generated to visualise the
homeostatic and stable state behaviours in these models by trial
and error and matched with experimental observations for
validation (Table 1 and 2). These parameters calculate the random
time delay variables for the time of activation and inhibition. The
petri net model exported in SBML format using Snoopy tool are
provided as Supplementary Files (1–3).
3.2.1 SPN model of Wnt/ β-catenin signalling: The biological
model of Wnt/ β-catenin in Fig. 6 is converted into SPN model
which is presented in Fig. 8. In the modelled petri net there are
many activators and inhibitors that are regulating the dynamics.
The transition rates of homeostatic and ARVC pathological
phenotype are given in Tables 3 and 4, respectively. In order to
model the pathology in the pathway, the rate of the mass actions is
tuned in accordance with experimental data cited in Table 1. In
SPN model initially, due to the inhibitor at place secreted frizzledrelated proteins (sFRPs), the Wnt ligand is suppressed and Wnt
signalling pathway is dysregulated as shown in Fig. 6. The
transitions of the system are labelled with ‘t’. The transition t1
IET Syst. Biol., 2020, Vol. 14 Iss. 6, pp. 350-367
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inhibits Wnt ligand when sFRPs token is present to lower the Wnt
level and the t2 transition suppresses the place sFRPs by place
miR28 at a high rate in Table 3, shown in Fig. 11a. The Wnt ligand
positively regulates the miR28 using the transition t3.
Table 3 shows the transition rates of homeostatic state of the
pathway where the high value of transitions shows that these
components recover the pathway from disease by decreasing
transition values of inhibitors at low transition rates in the table.
The transition t4 activates place Rspondin which regulates the
receptor at place LRP5/6 by t5, respectively, represented in
Fig. 11b. Through transition t6 at a high rate in Table 4 the place
marked by Dickkopf (DKK) inhibits the receptor LRP5/6 to inhibit
the binding of places Wnt and Frizz receptor in Fig. 12b. In the
absence of Wnt ligand, the Frizz receptor does not bind with it to
make a complex of place Wnt/Frizz to further activate the Wnt
pathway. The Wnt ligand and Frizz receptor with its co-receptor
LRP5/6 make a WLF complex at high transition rate t7 in Table 3
and shown in Fig. 12a. The transition t9 shows that WLFComplex,
Dvl and axin makes a new complex WLFA.
The Wnt/Frizz complex will further activate the place Dvl and
dephosphorylates β-catenin as shown in Fig. 13a by transition t8.
The Dvl further leads to inhibit the place GSK3 and degradation of
dephosphorylated β-catenin is prevented and in presence of Dvl it
translocates to the nucleus in Fig. 11b. The transition t10 shows the
translocation of β-catenin to the nucleus by the high rate of Dvl as
shown in Table 3.
The place Axin activates the places GSK3 and CK1 at t14 and
t15 which in turn phosphorylates the β-catenin and results in βcatenin degradation (Figs. 14a and b) and hence causes the ventral
fats. The places GSK3 and CK1 high transition rates at t16 in
Table 4 inhibit place Dvl and proceeds the β-catenin
355

Fig. 7 Wnt/Ca2 + signalling pathway shows calcium at different compartments as Ca2 + in cytoplasm (Ca_in) presented by orange colour, Ca2 + outside of cell
(Ca_Out) by Violet colour, Ca2 + in ER by Blue colour and Ca2 + in mitochondria (Ca_M) by Green colour, respectively

phosphorylation. Through t17, axin or β-catenin are not degraded
in the presence of this WLFA complex. The Tcf/lef activates place
Axin at transition t18.
The place PP2A inhibit β-catenin phosphorylation by
suppression of place GSK3 at transition t26 and place PP1 dephosphorylates the Axin by suppression of CK1 as presented in
Figs. 15a and b. Furthermore, in the SPN model the place APC and
Axin inhibit each other. The place APC inhibits the PP2A to
regulate negatively the β-catenin degradation in Fig. 16a. The
Tcf/lef activates place Axin at transition t18 which is presented in
Fig. 16b. At t27 CK1 is controlling PP1 and PP1 is recycled after it
has degraded CK1. Axin is an inhibitor and β-catenin is degrading
by Axin here inhibitor arc is not used to control both concentrations
otherwise they will rise high. By t21, PP2A is activated in the
absence of APC.
In Table 4 the high values of transitions show that these
components recover the pathway from disease by decreasing
values of inhibitors at low transition rates in the table.
The dephosphorylated β-catenin translocates to the nucleus and
activates the place Tcf/lef which results in activation of Wnt
responsive genes and suppresses the adipose tissues formation in
cardiomyocytes. Hence activates the Tcf/lef and anti-apoptosis gene
Bcl2 by transition t25. Through t19 transition, the places Axin and
APC activate each other. The transition t21 at a high rate as shown
in Table 4 suppresses the PP2A place to promote β-catenin
degradation. The t22 recycle to regulate the PP2A. When β-catenin
is accumulated in the nucleus, the Groucho separates from Tcf/lef
which results in activation of genes which positively regulates the
Wnt/ β-catenin signalling pathway through t10 and t23.
356

The β-catenin in absence of Wnt ligand make complex with
Axin, APC, GSK3 and CK1 and phosphorylated by high transition
rates of GSK3 and CK1 at transition t16, given in Table 4. β-TrCP
causes the proteosomal degradation of β-catenin at transition t29.
So the Tcf/Groucho represses Wnt target genes. The presence of
Wnt disrupts Axin mediated degradation of β-catenin allowing the
accumulation of β-catenin into the nucleus where it activates Wnt
responsive genes through Tcf/lef. The Nemo Like Kinase inhibits
the Tcf/lef at transition t24 to negatively regulates it.
3.2.2 SPN models of Wnt/Ca2 + signalling: The biological
model of Wnt/Ca2 + in Fig. 7 is converted into normal and
pathological SPN model as presented in Figs. 9 and 10
respectively. The mass action rates of transitions of pathological
SPN model (Table 5) are tuned according to the literature cited in
Table 6. The SPN models in Figs. 9 and 10 show the Ca2 + as
Ca_out (extracellular Ca2 + ), Ca_In (cytosolic_ Ca2 + ),
Ca_ER(Ca2 + in ER store) and Ca_mito (Ca2 + in mitochondria).
The action potential makes the Ca2 + enters to the cytoplasm by
VGCC and NMDR channels, the NCX and PMCA show the efflux
channels of Ca2 + . The Ca2 + enters the cytoplasm which induces
the release of Ca2 + from ER and the depletion of Ca2 + from ER
cause the influx of Ca2 + to ER [20].
The homeostatic SPN model is shown in Fig. 17a and the
transitions rates in Table 6 shows that the extracellular Ca2 + is
more than the intracellular Ca2 + but in the pathological model the
IET Syst. Biol., 2020, Vol. 14 Iss. 6, pp. 350-367
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Fig. 8 Wnt/ β-catenin SPN model shows that the Wnt signal keep GSK off and β-catenin translocate to nucleus to activate the Bcl2 gene by Tcf/lef. The PP1
and PP2A phosphatases in blue colour places are used as positive regulators to recover the pathway from disease state by inhibition of the GSK and Ck1 (its
high transition rate leads the pathway to pathology)

action potential increases the Ca2 + influx to cytoplasm even more
than extracellular Ca2 + presented in Fig. 17b.
In SPN the ER stress is shown by places IRE1, TRAF2, ASK
and JNK, and transitions (t40, t41, t42). The IRE1 activates ASK,
TRAF2 and JNK, respectively, where JNK inhibits the Bcl2 at
transition t43 by increasing the rate of transition to ‘1’ shown in
Table 5 which is pro-apoptotic component and presented in
Fig. 18a [18]. The bak&bax is activated by IRE1 at transition t44
which mediates mitochondrial apoptosis and Bcl2 inhibits the
bak&bax as shown in Fig. 18b [18].
The ER Ca2 + overload also activates the PERK and ATF which
further triggers the CHOP at transitions t45 and t46 having high
rates of transitions in Table 5, which inhibit the Bcl2 by t48
transition represented by Fig. 19a. The Wnt ligand activates the
place PLC at t1 and PLC activate the place Bcl2 at transition t37
which positively regulates the Ca2 + homeostasis presented in
Fig. 19b. So in the absence of Wnt ligand the Ca2 + pathway will be
dysregulated.
The increase of Ca2 + in cytoplasm activates mcalpain at t59
high transition rate in Table 5 which mediates the apoptosis by
activating caspase12, caspase9, caspase3 and then Parp by (t60,
t61 and t62, t63) finally cause apoptosis as shown in Fig. 20a. The
Ca2 + release from ER and moves into nearby mitochondria and the
Ca2 + elevation here rapture the mitochondrial membrane which
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releases the cytochrome C and Ca2 + in the cytoplasm to mediates
the apoptosis through aPf1, caspse9, caspse3 to activate the proapoptotic component (Parp) by (t51, t52, t53, t54, t62 and t63) as
presented in Fig. 20b [18].
The Bcl2 inhibits the release of Ca2 + from ER to Mitochondria
and cytoplasm at transition t51 to decrease the Ca2 + overload.
Normally, the Ca2 + moves out from mitochondria to ER at NCLX
channel which is presented by transitions (t49 and t50) and its rates
are shown in Table 5. The high level of Ca2 + influx into cell
deregulates the Ca2 + homeostasis by creating stress as shown in
Fig. 21.
The high level of extracellular Ca2 + creates stress in cytoplasm
through VGCC calcium channel shown in SPN model at transition
t33 in Fig. 10. The cytoplasmic stress of Ca2 + triggers the RyRs at
ER where outflow of Ca2 + occurs and Ca2 + moves into cytoplasm
as well as to mitochondria at t10 and t51, respectively. In both SPN
models of Wnt/ β-catenin and Wnt/Ca2 + in Figs. 8 and 10, the Wnt
ligand and Bcl2 plays important role. The absence of Wnt ligand
leads the pathway to disease state in both SPNs at transitions t1 in
Figs. 8 and 10. The anti-apoptosis gene Bcl2 in both SPNs used as
therapeutic target. In Wnt/ β-catenin as shown in Fig. 8, the Bcl2
gene positively regulates the Wnt ligand in opposition of sFRPs
inhibitor at transition t28. In Fig. 16 the SPN model of Wnt/Ca2 + ,
the Bcl2 gene recover cell from the ER and mitochondrial Ca2 +
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Fig. 9 SPN of Wnt/Ca2 + homeostasis model, the red colour place in SPN shows the Ca2 + in mitochondria. This model does not lead the signalling network
towards the apoptotic pathway

stress by inhibition of pro-apoptotic components JNK and
bak&bax.
The bak&bax activates mCalpain in the cytoplasm at high
transition rate in Table 5 having ‘1’ value at t59 and regulates the
pro-apoptotic component mCalpain, which is controlled by antiapoptosis gene Bcl2 as shown in Fig. 10. Moreover, the TRAF2
also regulates the Caspase12 at high transition rate of t58 in
Table 5. Hence the Bcl2 gene plays a vital role in Wnt signalling
pathway for recovery from ARVC disease through prevention of
adipose tissue formation in cardiomyocyte by positive feedback
loops and inhibition of pro-apoptotic components.

4 Therapeutic intervention
The parameters in Table 3 illustrate the reaction rates where the
tuning of the two important transitions, i.e. t12 and t13 show the
degradation of β-catenin by entities GSK3 and CK1, respectively.
This tuning of parameters successfully allowed us to view how the
progression of ARVC could be inhibited. In simulation graphs, it is
observed that as the rate of transition t16 is decreased then the βcatenin level (shown in Fig. 13b) is increased in network and goes
near the stability due to low activity of GSK3. Moreover, the rate of
t13 (set to 0.01) increases the level of β-catenin. In Fig. 14b, both
GSK and CK1 level reduction results in increased β-catenin level
which shows the dephosphorylation (De-pp) of β-catenin and its
translocation to the nucleus as a result Tcf/lef is activated and
prevents apoptosis. In Figs. 15(a and b, the phosphatases PP2A and
PP1 positively regulate the Wnt by inhibition of GSK3 and CK1 to
prevent the β-catenin phosphorylation by them. The PP1 and
PP2A high transition rates such as 1 as shown in Table 3 make the
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reaction fast. The Axin and APC at transition at t19 regulate each
other negatively which further suppress inhibition of β-catenin
phosphorylation. Moreover, in the absence or decreased level of
Wnt ligand the place Rspondin at transition t4 regulate the Wnt
pathway as shown in Fig. 11b. Tcf/lef activate the Bcl2 which is an
anti-apoptosis gene and further in the ARVC pathway prevent
adipose tissue formation in cardiomyocyte. The smaller level of
Axin results in less amount of activation of β-catenin inhibitory
components as GSK and CK1, which is maintained by β-catenin as
shown in Fig. 13b.
The SPN model of Wnt/Ca2 + in Fig. 10 shows that JNK inhibit
anti apoptotic gene Bcl2 at transition t43 by more cytoplasmic
Ca2 + because of action potential which causes ER stress as shown
in Fig. 21 and mediate the mitochondrial apoptosis by transition
t51 but the PLC at t37 which positively regulates Bcl2 to suppress
the activation of JNK and recover the Ca2 + homeostasis to prevent
ARVC. Overall these SPN models provide a good experimental
platform to generate testable hypotheses and may aid in designing
further experiments for therapeutic interventions. These models
have also increased our comprehension towards understanding the
underlying mutual dynamics of the two important signalling
pathways in pathophysiology of ARVC.

5

Conclusion

In ARVC, β-catenin has a central role as it degrades and creates
adipose tissues in cardiomyocyte. The fatty tissues formed from
ubiquitination of degraded β-catenin by bTrcp in Wnt signalling
pathway. The development of a given pathological pathway
increases due to activation of GSK3 and CK1. These inhibitors
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Fig. 10 SPN model of Wnt/Ca2 + for ARVC, this SPN shows the Ca2 + overload in cytoplasm and ER stress activates the apoptotic pathway by (IRE1, ASK,
TRAF2, JNK to inhibit the Bcl2) which further leads to mitochondrial apoptosis through activation of caspases and mCalpain

Table 1 Summary of comparison between reported experimental observations and simulation results for Wnt/ β-catenin
Signalling
S.No
Observations
Experimental findings Model simulation Citations
01
02
03
04
05

effect of Dikk0pf binding with LRP5/6 on Wnt signalling
Wnt signalling effects GSK3 via Dvl
Gkk3 and Ck1 effects b-catenin translocation to nucleus causes ARVC
Axin effects**** β-catenin degradation
effect of Bcl2 gene on Wnt signalling

—
—
—
+
+

—
—
—
+
+

[38]
[39, 40]
[41]
[42, 43]
[44]

Table 2 Summary of comparison between reported experimental observations and simulation results for Wnt/Ca2 + Signalling
S.no
Observations
Experimental finding Model simulations Citations
01
02
03
04
05

effect of JNK on Bcl2 causes ARVC
Bcl2 gene effect on mitochondrial Ca2+ overload
Bcl2 effect on bak&bax in down regulation of apoptosis
CHOP down regulates Bcl2 causes ARVC
ER stress promotes the Ca2+ overload in cytosol which causes apoptosis

—
—

—
—

[45–47]
[47, 48]

+
—
+

+
—
+

[47]
[47, 49]
[50]

06

effect of Ca2+ signalling on apoptosis (ARVC)

+

+

[8, 51]

07

Ca2+ influx upregulate calpain and induce apoptosis

+

+

[51, 52]

trigger the suppression of β-catenin De-pp. In SPN model all these
observations were implanted and analysed. The ARVC mechanism
is explained and we were able to derive some meaningful
observations. The first important observation is the low level of
Dvl in the absence of Wnt ligand dysregulates the Wnt pathway and
β-catenin starts to degrade gradually. The high rate of inhibitor
DKK also suppresses the LRP5/6 receptor to stop composition of
Wnt/Frizz complex that further activates the pathway. The regulator
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Rspondin of Wnt/ β-catenin pathway, which regulates the pathway
in the absence or low rate of Wnt ligand. Except that the PP1 and
PP2A phosphatases also regulate the β-catenin De-pp in a positive
feedback loop. The second important observation is when βcatenin accumulates in the nucleus and associate with Tcf/lef to
activate anti-apoptosis genes and Wnt responsive genes to
positively regulate the Wnt signalling pathway and also interlinked
pathways to reduce the progression of ARVC.
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Table 3 Transition rates of SPN model of Wnt/ β-catenin regulatory system during homeostasis
Transitions
Rate, µ
Transitions
t1
t2
t3
t4
t5
t6
t7
t8
t9
t10
t11
t12
t13
t14

0.1
1
1
1
1
0.01
1
1
1
10
1
1
0.01
0.5

Table 4 Transition rates of SPN model of Wnt/ β-catenin during ARVC
Transitions
Rate, µ
t1
t2
t3
t4
t5
t6
t7
t8
t9
t10
t11
t12
t13
t14

1
0.5
0.5
1
0.1
1
0.1
0.1
0.1
0.1
0.01
1
1
1

Rate, µ

t15
t16
t17
t18
t19
t20
t21
t22
t23
t24
t25
t26
t27
t28

0.5
0.01
1
1
0.5
1
0.5
0.1
1
0.5
1
0.1
0.1
1

Transitions

Rate, µ

t15
t16
t17
t18
t19
t20
t21
t22
t23
t24
t25
t26
t27
t28

1
1
0.1
0.1
1
1
1
1
0.1
1
1
1
1
0.1

Fig. 11 Up regulation and down regulation of Wnt ligand
(a) In the presence of sFRPs inhibitor, the Wnt ligand and the miR28 (which positively regulate the ligand) both are suppressed, (b) Wnt ligand is regulated positively by activators
LRP 5/6 and Rspondin

The interlinked pathway of Wnt/ β-catenin is Ca2 + signalling
pathway where the action potential influx more Ca2 + into cytosol
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and initiate the ER stress which further mediate the mitochondrial
apoptosis. The ER stress activates IRE1, TRAF2, ASK and JNK
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Fig. 12 The Wnt/Frizz inhibition and activation
(a) In the presence of Wnt and LRP5/6 the complex Wnt/frizz value is increased, (b) Inhibitor DKK lowered the Wnt/frizz level by supression of LRP5/6 activator

Fig. 13 Inhibition of β-catenin degradation
(a) Wnt/frizz complex activates Dvl and dephosphorylates β-catenin, (b) Activation of Dvl and inhibition of β-catenin degradation shows its binding with Tcf/lef

which inhibit the Bcl2. In result more Ca2 + from ER and cytosol
moves into Mitochondria to cause apoptosis and also the increase
of intracellular Ca2 + activates the mcalpain which activates
caspase, cascade to cause ARVC pathology. Here in Ca2 +
signalling pathway the Bcl2 which maintain the Ca2 + regulation
system by suppressing JNK and PLC is the main positive regulator
of Bcl2. By considering these observations, better therapeutic
interventions are warranted upon further pursual in wet lab
experiments. We also aim to extend this work by constructing
automata network models of the Wnt/ β-catenin and Wnt/Ca2 + for
the identification of stable states and biomarkers.
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Fig. 14 Degradation of β-catenin
(a) Ck1 and GSK3 are activated by axin, (b) Ck1 and GSK3 degraded the β-catenin

Fig. 15 Down regulation of β-catenin phosphorylation
(a), (b) PP2A inhibits the GSK3 and PP1 inhibits CK1 to reverse the β-catenin phosporylation
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Fig. 16 Up and down regulation of Axin
(a) PP2A and APC negatively regulate each other, (b) Tcf/lef regulates positively the Axin

Table 5 Transition rates of Wnt/Ca2 + pathological model
Transitions
Rate, µ
t38
t39
t40
t41
t42
t43
t44
t45
t46
t47
t48
t49
t50

0.1
0.01
0.1
0.1
0.01
0.1
0.1
1
0.01
1
1
1
1

Table 6 Transition rates of Wnt/Ca2 + homeostatic model
Transitions
Rate, µ
t1
t2
t3
t4
t5
t6
t7
t8
t9
t10
t11
t12
t13
t14
t15
t16
t17
t18
t19
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1
1
1
1
1
1
1
1
1
1
1
1
1
1
0.1
1
1
1
1

Transitions

Rate, µ

t51
t52
t53
t54
t55
t56
t57
t58
t59
t60
t61
t62
t63

1
1
1
1
1
1
1
1
1
1
1
1
1

Transitions

Rate, µ

t20
t21
t22
t23
t24
t25
t26
t27
t28
t29
t30
t31
t32
t33
t34
t35
t36
t37
t38

1
1
1
1
0.1
1
1
1
1
1
1
1
0.1
1
1
1
1
1
1
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Fig. 17 The Ca2+ homeostasis and dysregulation of homeostasis in many compartments of cardiomyocyte
(a) Shows the normal Ca_in and Ca out, Ca_ER and Ca_mitochondria, (b) Shows the action potential increased the Ca_in so much even more than Ca_out

Fig. 18 The activation of Apoptotic pathways and its inhibition by Bcl2
(a) Increase of Ca-ER, C-In activates the IRE1 which activates ASK, TRAF, JNK and JNK inhibit the Bcl2 and vice versa, (b) Decrease of Ca_ER and Ca_In activates the Bcl2 and
Bcl2, inhibits the bak&bax and lowers the level of Ca2 + in mitochondria
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Fig. 19 The effect of Bcl2 on Mitochondrial and ER Ca2+ regulation
(a) Increase of CHOP decreases Bcl2 level increases the Ca2 + in mitochondria, (b) In the presence of PLC the Bcl2 increases which inhibits the JNK and vice versa

Fig. 20 Mitochondrial Apoptosis
(a) Ca_ER and bak&bax release calcium into mitochondria (Ca mito) which release the cytc into the cytoplasm and activates the Casp9, Casp3 and then Parp (pro-apoptosis), the
NCLX move calcium out of mitochondria into ER in the normal way (not in pathology), (b) Increase of Ca2 + in ER and cytoplasm activates the mCalpain, which activates the
caspase cascade and rises the level of parP_aPOPTOSIS
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Fig. 21 Stress created by Ca2 + high-level outside increases the Ca_in, Ca_ER and Ca_mitochondria
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